Consistent with these findings, our group demonstrated that knockdown of PKCε with RNAi decreases in vitro invasion and motility [45,46], as well as incidence of lung metastases in a pre-clinical animal model of breast cancer [45]. Here, PRKCE is linked to breast carcinoma.